About Vyome Biosciences Private Limited
Data last updated:
Vyome Biosciences Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 August 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33110GJ2010PTC099141. Its GSTIN is 07AADCV3774A1ZH (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹33.46 Lakh. It is led by directors including Rajeev Mantri and Shiladitya Sengupta.
Its last annual general meeting (AGM) was held on 28 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C4 – 201 Akshar Pavilion Priya Cinema Road, Vadodara, Gujarat, India – 390021.
As per the financials filed for FY 2025, the company reported a revenue of ₹40,161, a decline of 96% compared to the previous year. For the same year it recorded a net loss of ₹2.94 Lakh and EBITDA of -₹2.94 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 69% over three years and 63% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
The company is associated with 2 brands: Olique and Vyome Therapeutics. The company has 11 deals on record (5 funding rounds, 4 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹153.49 Cr; the latest was in December 2018. The company has 7 MSME Form 1 returns on record between 2019 and 2022, listing 30 overdue payments to 3 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vyome.in.
Company details
CIN history
Vyome Biosciences has one previous CIN (Corporate Identification Number): U33110DL2010PTC207299. The current CIN is U33110GJ2010PTC099141, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33110GJ2010PTC099141 | Current |
| U33110DL2010PTC207299 | Previous |
Contact details
Vyome Biosciences Private Limited's registered office is in Vadodara, Gujarat. Its website is vyome.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressC4 – 201 Akshar Pavilion Priya Cinema Road, Vadodara, Gujarat, India – 390021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vyome Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Vyome Biosciences operates two associated brands: Olique and Vyome Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers innovative anti-dandruff and anti-hairfall oils and shampoos for consumer hair health. | olique.in | |
| Small molecule therapeutics for immuno-inflammatory conditions are developed. | vyometx.com |
Financials of Vyome Biosciences Private Limited
FY 2025 filings availableVyome Biosciences Private Limited reported revenue of ₹40,161 (down 96% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 63% over five years, including a 96% fall in the latest year. EBITDA rose 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.94 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.94 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vyome Biosciences Private Limited, buy the company report.
Board of directors of Vyome Biosciences Private Limited
Vyome Biosciences has 5 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Mantri Also directs: Invictus Oncology Private Limited, Akamara Biomedicine Private Limited, Navam Technology Ventures LLP and 5 more | Director | 30 Mar 2019 | 7 Years 7 Months | Current |
| Shiladitya Sengupta Also directs: Invictus Oncology Private Limited, Akamara Biomedicine Private Limited, Vyome Therapeutics Limited and 1 more | Director | 19 Aug 2010 | 16 Years 2 Months | Current |
| Ranjana Kumar Also directs: Vyome Therapeutics Limited | Director | 03 Nov 2010 | 16 Years 0 Months | Current |
| Krishna Kumar Gupta | Director | 29 Nov 2018 | 7 Years 11 Months | Current |
| Venkateswarlu Nelabhotla Also directs: Vyome Therapeutics Limited, Ezitaa Health & Wellness Private Limited, Pulse Pharmaceuticals Private Limited and 1 more | Director | 30 Sep 2013 | 13 Years 1 Months | Current |
Auditor
Vyome Biosciences Private Limited is audited by Saxena & Saxena for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Saxena & Saxena | FY 2022 | 006103N |
Shareholding
The shareholding of Vyome Biosciences Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vyome Biosciences Private Limited, buy the company report.
Deals & funding
Vyome Biosciences Private Limited has 11 deals on record (5 funding rounds, 4 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹153.49 Cr; the latest was in December 2018.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2018 | Secondary share transfer | Undisclosed | Buyer: Remus Capital (Romulus Capital) Seller: Navam Capital |
| Nov 2018 | Secondary share transfer | Undisclosed | Buyer: Remus Capital (Romulus Capital) Seller: Sabre Partners Private Equity |
| Aug 2017 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Vyome Bioscience Trust |
| Jul 2016 | Funding round · Series C | ₹89.93 Cr | Investors: Perceptive Advisors, Kalaari Capital, Remus Capital (Romulus Capital) |
| Sep 2015 | Funding round · Series B | ₹17.71 Cr | Investors: Sabre Partners Private Equity, Kalaari Capital, Aarin Capital |
To see the full deal history of Vyome Biosciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Vyome Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Vyome Biosciences Private Limited has 7 MSME Form 1 returns on record between 2019 and 2022, listing 30 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Blak & Co. | |||
| Vyome Therapeutics Limited | |||
| Haribhakti & Co. LLP |
To see the full MSME payment records of Vyome Biosciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Vyome Biosciences Private Limited has a workforce of 1 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Vyome Biosciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCV3774A1ZH | Delhi | Active | 01 Jul 2017 |
| 36AADCV3774A1ZG | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vyome Biosciences Private Limited, buy the company report.
Recent activity
Vyome Biosciences Private Limited has 27 board changes on record since 2010: 16 appointments and 11 cessations. The latest: Christopher Nishan Garabedian ceased to be Director on 30 Mar 2019.
18 earlier events are in the company report.
News
Frequently asked questions
Vyome Biosciences is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 August 2010 (16+ years old) and is registered under CIN U33110GJ2010PTC099141.
Vyome Biosciences has 5 current directors:
- Rajeev Mantri - Director
- Shiladitya Sengupta - Director
- Ranjana Kumar - Director
- Krishna Kumar Gupta - Director
- Venkateswarlu Nelabhotla - Director
The latest financial statements of Vyome Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vyome Biosciences is 07AADCV3774A1ZH, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AADCV3774A1ZG (Telangana).
The CIN (Corporate Identification Number) of Vyome Biosciences is U33110GJ2010PTC099141. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vyome Biosciences was incorporated on 19 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Vyome Biosciences has 11 deals on record (5 funding rounds, 4 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹153.49 Cr; the latest was in December 2018.
Christopher Nishan Garabedian ceased to be Director on 30 Mar 2019. Rajeev Mantri was appointed as Director on 30 Mar 2019. Kumar Shiralagi ceased to be Director on 28 Mar 2019. Vyome Biosciences has 27 board changes on record in total.
Vyome Biosciences has 7 MSME Form 1 returns on record between 2019 and 2022, listing 30 overdue payments to 3 micro and small suppliers. The latest return was filed on 13 Feb 2023.
Vyome Biosciences can be reached through the website vyome.in. Its registered office is in Vadodara, Gujarat, India.
The registered office of Vyome Biosciences is at C4 – 201 Akshar Pavilion Priya Cinema Road, Vadodara, Gujarat, India – 390021.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
